Top & Current
Fri, March 15, 2024
[ Fri, Mar 15th 2024
] - WOPRAI
Wed, March 6, 2024
[ Wed, Mar 06th 2024
] - WOPRAI
Mon, October 4, 2021
[ Mon, Oct 04th 2021
] - WOPRAI
Tue, August 10, 2021
[ Tue, Aug 10th 2021
] - WOPRAI
Tue, May 18, 2021
[ Tue, May 18th 2021
] - WOPRAI
Thu, March 11, 2021
[ Thu, Mar 11th 2021
] - WOPRAI
Thu, May 28, 2020
[ Thu, May 28th 2020
] - WOPRAI
Tue, March 31, 2020
[ Tue, Mar 31st 2020
] - WOPRAI
Mon, February 10, 2020
[ Mon, Feb 10th 2020
] - WOPRAI
Fri, December 13, 2019
Wed, September 4, 2019
[ Wed, Sep 04th 2019
] - WOPRAI
Mon, April 15, 2019
[ Mon, Apr 15th 2019
] - WOPRAI
Wed, January 23, 2019
Tue, November 13, 2018
[ Tue, Nov 13th 2018
] - WOPRAI
Fri, July 21, 2017
[ Fri, Jul 21st 2017
] - WOPRAI
Thu, March 30, 2017
[ Thu, Mar 30th 2017
] - WOPRAI
Esther Rajavelu Maintained (APLT) at Strong Buy with Increased Target to $13 on, Mar 15th, 2024
Esther Rajavelu of UBS, Maintained "Applied Therapeutics, Inc." (APLT) at Strong Buy with Increased Target from $12 to $13 on, Mar 15th, 2024.
Esther has made no other calls on APLT in the last 4 months.
There are 2 other peers that have a rating on APLT. Out of the 2 peers that are also analyzing APLT, 0 agree with Esther's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Esther
- Joseph Schwartz of "Leerink Partners" Initiated at Buy and Held Target at $12 on, Thursday, February 22nd, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $7 on, Friday, February 16th, 2024